The core decision: one operation or two?

For anyone told they need surgical cartilage repair, the most immediate practical question is often not which technique sounds most advanced — it is how many operations are involved and how long recovery will take.

AMIC (autologous matrix-induced chondrogenesis) completes the repair in a single theatre visit. The surgeon makes small holes in the bone beneath the damaged cartilage to release bone-marrow stem cells, then covers the area with a collagen scaffold that holds those cells in place while new tissue forms. ACI (autologous chondrocyte implantation) works differently: a first procedure harvests a small sample of the patient's own cartilage cells, which are then grown in a laboratory over several weeks before a second operation reimplants them under a protective membrane.

At the headline level, the research suggests outcomes are broadly similar. A 2024 network meta-analysis drawing on 19 randomised controlled trials found no statistically significant difference in patient-reported outcomes between AMIC, ACI, and other cartilage repair techniques at any follow-up point — short, medium, or long term.

That population-level equivalence is genuinely reassuring, but it does not make the two procedures interchangeable. Defect size, its location in the knee, the patient's age and activity level, and factors such as previous surgery all influence which approach is more appropriate. Those specifics are covered in the sections that follow.

What each procedure involves, step by step

The theatre experience for each approach differs in ways that matter practically, quite apart from the biological differences already described.

AMIC unfolds as a single procedure. After exposing the defect, the surgeon creates microfracture channels through the underlying bone — a step that draws bone-marrow stem cells into the repair zone. A collagen scaffold, typically Chondro-Gide, is then cut to fit the defect precisely and fixed over those channels, giving the released cells a structured matrix in which to consolidate. One anaesthetic, one recovery arc.

ACI divides the repair across two separate operations. The first is relatively short: a small plug of healthy cartilage is harvested arthroscopically from a low-load region of the same knee and sent to a laboratory, where the cells are isolated and expanded over approximately three to six weeks. The second, longer procedure returns those multiplied cells to the knee, placed beneath a protective collagen membrane secured over the defect. Patients therefore face two anaesthetics and two distinct recovery periods.

For defects that exceed what standard AMIC reliably addresses, an augmented variant — sometimes called AMIC Plus — incorporates concentrated bone marrow aspirate alongside the scaffold, extending the technique to larger or critically sized lesions.

Both procedures require structured post-operative rehabilitation, with athletic return broadly in the region of ten to twelve months for either approach. In the UK, ACI is performed roughly three times as often as AMIC — 176 versus 61 procedures over five years across 19 centres — a gap that reflects established referral patterns rather than any proven clinical advantage of one technique over the other.

When ACI tends to be the stronger choice

Three scenarios tend to shift the balance clearly towards ACI.

Large defects

For lesions measuring 4–12 cm², ACI has the most robust evidence in this size range. A Phase III trial in 100 patients showed KOOS rising from 39.8 before surgery to 84.7 at five years — a mean gain of 44 points — with 92.8% classified as responders and a treatment failure rate of only 1%. Comparable long-term data for AMIC at this scale are thinner, which is why larger defects are more likely to be directed towards cell-based repair.

Patellofemoral location

When the defect sits on the patella or within the trochlear groove, clinical treatment algorithms broadly favour ACI. Return-to-sport rates of 67% in professional American football players and 54% in a general population series (mean age 32) illustrate what ACI can achieve in this mechanically demanding location.

Revision after a prior repair

If a previous cartilage procedure has broken down, ACI is generally the preferred next step — with one important caveat. Prior marrow-stimulation surgery increases ACI failure risk, so the type of original procedure matters when planning revision.

Who tends to respond best to ACI

Once ACI is indicated, individual patient factors also shape how well it performs. A study following 112 patients for a mean of 11 years after matrix-ACI found that male sex (OR 3.1) and a BMI in the range 20–29 (OR 3.9) independently predicted achieving a patient-acceptable symptom state. Female sex and higher BMI were associated with less favourable outcomes — factors that inform realistic expectations rather than absolute eligibility criteria.

When AMIC tends to be the stronger choice

Finishing in a single operation suits more patients than might initially seem obvious — and for the right candidate, AMIC delivers that without compromising the repair.

Smaller-to-medium defects (roughly 2–4 cm²)

A 7-year retrospective series of 21 patients found AMIC effective across the full range of full-thickness defects above 2 cm², with no correlation between defect size and clinical outcome. A registry of 57 patients (mean age 37.3 years; mean defect 3.4 cm²) showed significant reductions in VAS pain and functional gains at both one and two years. Within this defect-size window, the evidence for durability is established.

Younger and athletic patients

For adolescents aged 12–19 with lesions averaging 2.3 cm², AMIC produced significant KOOS gains at 2.6 years — including sports and leisure scores rising from 29% to 73% — though some patients remained symptomatic. Case data in professional sport also point to return to competition at around ten months, which aligns with the wider literature for both techniques.

When a second operation is genuinely difficult

The Fossum et al. RCT (41 patients) comparing ACI-C directly with AMIC in distal femur and patella defects found comparable clinical outcomes and MRI tissue fill in both arms. AMIC is not a compromise route to similar results — it is an equivalent route that removes the cell-culture interval and second anaesthetic.

A 2021 Bayesian network meta-analysis of 2,220 procedures (36 studies) found AMIC numerically superior on Lysholm (SMD 3.97) and Tegner (SMD 2.10) scores at approximately three years, with the lowest observed failure and revision rates. That numerical edge, however, most plausibly reflects AMIC's advantage over microfracture within the data pool rather than a definitive superiority over ACI — a distinction worth keeping in view when reading those figures.

Patient factors that shift the decision

Surgeons assessing a cartilage defect look beyond lesion measurements. The most consistent finding from a systematic review of 8,905 procedures across all cartilage repair techniques is that pre-operative functional status outperforms defect size and symptom duration as a predictor of outcome — patients who are functioning reasonably well before surgery tend to recover better, regardless of which procedure is chosen. Neither how long symptoms have been present nor the size of the lesion was associated with surgical outcome in that review, which challenges the assumption that a smaller defect automatically means an easier recovery.

Smoking is the clearest technique-specific contraindication in this literature. Active smokers face an odds ratio of 3.7 for graft complications after AMIC — primarily deep fissuring — in a series of 130 procedures; prior cartilage repair surgery carried a similarly significant association. Together, these findings mean AMIC is generally not offered to active smokers or in revision settings following a previous cartilage procedure. ACI does not carry this specific published contraindication, though smoking is broadly unfavourable for surgical healing across procedures.

Body weight and surgical history affect prognosis for both techniques. Higher BMI is strongly associated with graft hypertrophy, and multiple prior knee operations worsen outcomes irrespective of which procedure follows. Where abnormal lower-limb alignment is loading the damaged compartment — as in varus or valgus malalignment — a corrective osteotomy (HTO or DFO) may be discussed alongside either AMIC or ACI rather than as a separate pathway, since realigning the joint reduces the mechanical stress the repair must withstand.

The practical upshot is that defect dimensions provide a starting point for decision-making rather than a verdict. Functional status, smoking history, BMI, prior surgery, and joint mechanics together carry more predictive weight than lesion size alone — and a consultant assessment that draws on all of these gives a more reliable picture than any single measurement.

How to find the right specialist for your situation

Seeking out a specialist cartilage unit makes a practical difference. Not every orthopaedic department offers both procedures, and a surgeon experienced in only one technique is less well placed to weigh the two options against your specific clinical picture — defect location, lifestyle, smoking history, and any prior knee surgery all bearing on the decision in ways the preceding sections have outlined.

Two questions worth raising at a first consultation: "Do you perform both AMIC and ACI, and how do you choose between them for a patient like me?" and "How many of each have you done?" A consultant who can answer both directly is in a stronger position to guide the choice than one whose practice leans exclusively in one direction.

Standard pre-operative workup includes MRI to characterise defect size and location, alongside a formal discussion of prior procedures, alignment, and functional goals. No cartilage repair decision should follow from imaging alone.

The head-to-head trial evidence beyond five years remains limited — not a reason to delay treatment, but a reason why the surgeon's clinical experience carries particular weight when data do not yet point clearly in one direction. Search MSK lists knee cartilage specialists across the UK, searchable by region and by the specific procedures they offer, making it straightforward to identify a consultant equipped to discuss both approaches.